ArisGlobal updates adverse event reporting platform

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/BrianAJackson)
(Image: iStock/BrianAJackson)
ArisGlobal has launched a new platform to report potential adverse events in response to technology trends, which necessitate the immediate availability of information.

Available as a web-based portal or mobile app, the platform – LifeSphere Mobile MA – allows users to access approved product content, report potential adverse events (AEs), and submit medical inquiries and product quality complaints, according to the cloud-based software solutions provider.

To ensure compliance with regulatory directives, all life sciences companies need to provide robust and efficient processes for reporting and evaluating adverse events and product complaints​,” Simon Sparkes, executive vice president, ArisGlobal, told

According to Sparkes, self-service capabilities are becoming increasingly important because of changing technology trends and the expectation to provide immediate information.

For many companies, the current mechanisms for reporting and evaluating adverse events and product complaints are laborious and time-consuming, which often discourages healthcare professionals, patients and internal field-based teams from reporting​,” he said.

FDA and EMA update adverse event reporting systems

To address many of these issues​, both the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have both made changes​ to improve adverse event tracking.

The EMA today launched​ its a new and improved version of EudraVigilance, the agency’s information system of suspected adverse events.

The launch of the new system, which tracks events related to medicines that are authorized or being studied in clinical trials in the European Economic Area (EEA), involved the transfer of more than 11m individual case safety reports from clinical trials and post-authorization, the agency said.

According to the EMA, “the new system makes it easier for marketing authorization holders and sponsors of clinical trials to report suspected adverse reactions and allows for better analysis of this information for the benefit of patient safety in Europe​.”

Stateside, the US Food and Drug Administration (FDA) also recently launched an online tool to improve access to adverse event information for consumers, providers, and researchers.

Related news

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more